openPR Logo
Press release

Drug Eluting Balloon Market to Witness Significant Growth During the Forecast Period

06-12-2019 02:59 PM CET | Industry, Real Estate & Construction

Press release from: DataM Intelligence 4Market Research

Drug Eluting Balloon Market to Witness Significant Growth

DataM Intelligence 12 Jun 2019
Dallas, USA
The market report titled ‘Global Drug Eluting Balloon Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.

Drug Eluting Balloon Market Drivers
The global drug eluting balloon market is primarily driven by increasing demand for drug-coated balloons over the standard Percutaneous Transluminal Angioplasty (PTA), balloons for treating peripheral and coronary arterial diseases. In addition, the market growth is also expected to be high due to rapidly increasing technological advancements in drug eluting balloon.
The rising prevalence of heart diseases and the ageing population are key factors driving the growth of drug eluting balloon market. For instance, according to the Centers for Disease Control and Prevention (CDC), more than 15 million Americans suffer from coronary heart disease, which makes it the most common type of heart disease, which results in the deaths of over 370,000 people, annually. In most cases, the progression of CADs (Coronary Artery Diseases) becomes clinically apparent by the age of 40. However, the patients aged 65 years or more account for approximately 85% of the total deaths from CAD.

Request for the free sample of the report -

Drug Eluting Balloon Market Segmentation
On the basis of product type, peripheral drug eluting balloon, the peripheral drug eluting balloon segment accounted for the largest market share in 2018 and expected to dominate over the forecast period (2019-2026). The segment is growing due to growing usage of drug eluting balloon in the treatment of peripheral artery diseases as these devices are easy to use and the treatment shows improved patency rate as compared to that of standard PTA balloons. In addition, the growth of the peripheral drug eluting balloon segment attributed to the increasing development in these devices by major players.
On the basis of drug coating technology, the FreePac segment held the largest market share in 2018 and growing at a significant CAGR over the forecast period due to entry of several new drug coating technologies in the market.

Drug Eluting Balloon Market Regional Analysis
In Asia-Pacific, the market size of drug eluting balloon market is contributed by major countries such as China, and India. The region is growing due to several initiatives taken by governments to increase awareness about therapeutic applications of drug-eluting balloons in coronary and peripheral artery diseases. In addition, the aging population and increased investments by many foreign medical device companies fuelled the growth of the drug-eluting balloons market in the region. According to UN, approximately 30% of the total population in China is estimated comprise elderly people by 2050. Developing countries, such as India and China, are expected to have a larger geriatric population base compared to developed countries, such as the U.S. For instance, the number of people aged above 60 years is expected to reach 437 million in China and 324 million in India compared to 107 million in the U.S. by 2050. Hence, the demand for drug eluting balloon devices is increasing in this region, leading to the growth of the market.
Drug Eluting Balloon Market Company Trends
Some of the major players in the Drug Eluting Balloon market include Medtronic, Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Biotronik, Acotec Scientific, among others. The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches along with the increased focus on R&D are other ways the leading players improve their market presence.

To know more information about the report -

Table of contents overview -
1.Global Drug Eluting Balloon Market Methodology and Scope
2.Global Drug Eluting Balloon Market – Market Definition and Overview
3.Global Drug Eluting Balloon Market – Executive Summary
4.Global Drug Eluting Balloon Market – Market Dynamics
5.Global Drug Eluting Balloon Market – Industry Analysis
6.Global Drug Eluting Balloon Market – By Product Type
7.Global Drug Eluting Balloon Market – By Drug Coating Technology
8.Global Drug Eluting Balloon Market – By End-Users
9.Global Drug Eluting Balloon Market – By Region
10. Global Drug Eluting Balloon Market – Competitive Landscape
11. Company Profiles
12. Global Drug Eluting Balloon Market – Premium Insights
13. Global Drug Eluting Balloon Market – DataM

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana


+1 877-441-4866

About DataM Intelligence
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historical data but also allows a highly justifiable forecast model.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Market to Witness Significant Growth During the Forecast Period here

News-ID: 1773244 • Views: 225

More Releases from DataM Intelligence 4Market Research

Metal Injection Molding Market Analysis, Application, Regional Outlook, Competit …
Metal injection molding is a metalworking process in which finely powdered metal is mixed with binder material to create a feedstock that is then shaped and solidified using injection molding. The molding process allows high volume, complex parts to be shaped in a single step. After molding, the part undergoes conditioning operations to remove the binder and densify the powders. The global metal injection molding market size was worth USD YY
Medical Imaging Market Growing at a CAGR of 5.50% During the Forecast Period
DataM Intelligence’s latest market report titled ‘Global Medical Imaging Market– Size, Share and Forecast (2019-2026)’ reflects the size, scope, industry dynamics, major firms and future trends in this market. Medical Imaging Market Dynamics The growth of the medical imaging market size is driven by several factors such as the increase in the prevalence of chronic diseases, the technological advancement in the pharmaceutical industry and the investments by government and private organizations. However,
Chlorinated Polyethylene Market Global Industry Analysis and Growth Factors Duri …
DataM Intelligence’s latest market report titled ‘Global Chlorinated Polyethylene Market– Size, Share and Forecast (2019-2026)’ reflects the size, scope, industry dynamics, major firms and future trends in this market. Chlorinated Polyethylene Market Drivers The demand for chlorinated polyethylene market is driven due to the replacement of wood and steel with plastics in the manufacturing of doors and windows. With the development of PVC plastic profiles for doors and windows, the demand
High Strength Aluminium Alloys Market Expected to Grow at a CAGR of 7.2% by 2026
‘Global High Strength Aluminium Alloys Market – Size, Share and Forecasts (2019-2026)’ from DataM Intelligence provides expert analysis into the market share, size, industry outlook, volume, major manufacturers and future trends in this industry. High Strength Aluminium Alloys Market Dynamics Increasing demand for lightweight and corrosion resistance in automotive parts have pushed high strength aluminum alloys at the forefront of these industries. The perfluorocarbons released during the smelting process of aluminum is

All 5 Releases

More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample - Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning